Welcome to the AHA Heart Failure Community
AHA Heart Failure Community Editor
John B. O'Connell, MD, FAHA
John B. O'Connell, MD, FAHA
Council on Clinical Cardiology
|
Featured Biomarker Article
Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the
Community
Shannon M. Dunlay, Yariv Gerber, Susan A. Weston, Jill M. Killian, Margaret M. Redfield, and Véronique L. Roger Circ Heart Fail 2009;2 393-400
Are Multiple Biomarker Testing Strategies Ready for Prime Time in Heart Failure?
Douglas S. Lee and Jack V. Tu Circ Heart Fail 2009;2 387-388 Conferences and Events
Heart Failure Society of America 14th Annual Scientific Meeting
September 12-15, 2010 San Diego, California Announcements
Get with the Guidelines
Get With The Guidelines SM (GWTG) is an evidence-based program for in-hospital quality improvement, ensuring that the care provided to coronary artery disease, stroke and heart failure patients is aligned with the latest scientific guidelines - More information
This case review shows how one hospital used the Plan Do Study Act (PDSA) methodology to improve their identification of heart failure patients.
GWTG-HF - Fact Sheet The fact sheet outlines the measures and data elements for Get With The Guidelines - Heart Failure.
HealthJobsPlus
Find the perfect job or let your dream job find you. Visit HealthJobsPlus today.
|
Welcome to the AHA Heart Failure Community
AHA Heart Failure Community Editor
John B. O'Connell, MD, FAHA Council on Clinical Cardiology Science News
AHA Scientific Sessions 2009
Check here information on FAIR-HF, a Late Breaking Clinical Trial related to Heart Failure.
AHA Scientific Sessions 2008
Late Breaking Clinical Trials Related to Heart Failure include HF-ACTION, HF-ACTION Substudy, I-PRESERVE, BACH Multinational, and BICC.
Statements and Guidelines
Commentaries
Heart Failure Guidelines: a Dynamic DocumentJohn B. O'Connell, MD, FAHASupporting MaterialsAtrial Fibrillation Ablation and Congestive Heart Failure: Where Are We Going?Dr. Kenneth Ellenbogen, MD, FAHAHFpEF: The Therapeutic Mystique PreservedDr. John B. O'Connell, MD, FAHA
Clinical Updates
Soluble ST2 for Predicting Sudden Cardiac Death in Patients with Chronic Heart Failure and Left Ventricular Systolic DysfunctionJeffrey Hosenpud, MD, FAHAHeartMate II: A Reliable DestinationJohn B. O'Connell, MD, FAHACardiac Resynchronization Therapy for the Prevention of Heart-Failure EventsKenneth Ellenbogen, MD, FAHA
Articles of Interest
Chocolate Intake and Incidence of Heart Failure: A Population-Based, Prospective Study of Middle-Aged and Elderly WomenElizabeth Mostofsky, et al.Published Online on August 16, 2010Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular DysfunctionAaron L. Baggish, et al.Circulation: Heart Failure. 2010;3:472-476Abstract | Full Text | PDF | Data Supplement Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38α MAP KinaseMediated, Nitric OxideDependent Mechanisms in Conscious Dogs With Dilated CardiomyopathySiva Bhashyam, MD, et al.Circulation: Heart Failure. 2010;3:512-521Abstract | Full Text | PDF | Data Supplement
AHA Journals
|